Navigation Links
Kerr Drug to Deploy Mirixa Technology for Clinical Services
Date:8/18/2010

RESTON, Va., Aug. 18 /PRNewswire/ -- The Mirixa Corporation is pleased to announce that Kerr Drug has signed a licensing agreement for MirixaEdge(SM), Mirixa's clinical application that supports the delivery of pharmacist-based patient care services, including Medication Therapy Management (MTM). Awarded a grant to support delivery of patient care services by community pharmacists, Kerr will be offering MTM services to the City of Charleston, SC and Charleston Water Works employees and will utilize MirixaEdge as the technology platform for this effort.

(Logo: http://photos.prnewswire.com/prnh/20100818/SF51721LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100818/SF51721LOGO)

Kerr evaluated a number of MTM platforms to support the grant initiative. Central to the decision to partner with Mirixa was the robustness of the MirixaEdge application functionality.  Rebecca W. Chater, RPh, MPH, FAPhA, Executive Vice President for Kerr Drug feels the MirixaEdge software with its programmatic approach to chronic disease management is in alignment with Kerr's focus on developing new clinical services. "In order to ensure consistency of clinical service delivery across our pharmacies, we need a tool like MirixaEdge to provide the framework for guiding an interactive discussion between the pharmacist and the patient. The MirixaEdge application has the right level of structure, along with disease-specific inquiries, that will be of great benefit to our customers and staff."  

Kerr Drug will utilize the Mirixa technology to track the progress of employee medication regimens, to provide patient educational information, and to report on outcomes achieved through MTM service delivery. Kerr has established itself as a leader in providing pharmacist-supervised patient care services and this grant will help Kerr to further measure the reach of its programs.

Tony Civello, President & CEO of Kerr Drug views this initiative as another example of Kerr's drive to provide patients, health plans and the medical community with the most comprehensive and convenient health and wellness programs. "Our mission is to position the role of the pharmacist and the pharmacy as more than just a dispensing function. Pharmacists have extensive clinical knowledge that should be leveraged by patients to better understand their medications and how to take them. The MirixaEdge application will help us capture and ultimately measure the value our patients are receiving."

Mirixa is pleased to be joining forces with Kerr Drug in helping to improve the health of the employees of the City of Charleston and the Charleston Water Works. Rick Solano, CEO of Mirixa explains, "Kerr looked extensively at technology partners for this project and we are delighted with their selection of MirixaEdge. Kerr stores will join other forward- looking pharmacies that are using MirixaEdge as part of a patient-centric disease management program."

About MirixaMirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the health care community to deliver patient care services through retail pharmacy. The MirixaPro(SM) web-based clinical platform is used by pharmacists to deliver standardized patient care services. For more information, please visit www.Mirixa.com.

About Kerr Drug Kerr Drug is one of the most recognized and respected names in the chain drug industry. With its roots in the Carolinas and headquarters in Raleigh, N.C., Kerr Drug's strategic direction is founded in its unique ability to provide patients, the medical community, and health plans access to the most comprehensive and convenient health and wellness offering in the industry. With a mission to be the most comprehensive provider of pharmacy and related healthcare services, while continuing to be the most reliable provider of health-related and convenience items, Kerr is currently providing services that far exceed the traditional drug store mix. For more information, please visit www.kerrdrug.com.Media Contact:Mirixa:

Anne Marie Heil703.865.2035amheil@Mirixa.com
'/>"/>

SOURCE Mirixa Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IMPLANET Raises Additional EUR 8 Million (USD 11 Million) to Fuel Deployment
2. First Coast Oncology Deploying Both Naviscan(TM) PEM and AccuBoost(TM) Assisted Therapy to Optimize Breast Cancer Treatment
3. University of Kansas Hospital Deploys NeoFax from Thomson Reuters for Electronic Neonatal Drug Dosing to Support Medication Safety
4. Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Deploys Isilon IQ in Next Generation of Drug Development
5. University of Kansas Medical Center to Deploy Velos eResearch System-Wide
6. Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivessel Disease
7. Mirixa Australia Achieves Six Month Milestones
8. Mirixa Corporation Announces MirixaEdge(SM)
9. Mirixa Corporation Announces Key Pharmacy Network Hire
10. Varian Medical Systems to Showcase Advanced Motion Management Technology for the Treatment of Lung Cancer at CHINA-HOSPEQ 2010
11. US Oncology Announces Addition of John Osborn as EVP & General Counsel and Asif Ahmad as EVP of Technology Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... According to a new market ... 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application ... Manufacturers, Hospitals/ Clinics) - Forecast to 2021", published by ... for the forecast period of 2016 to 2021. This ... 2021 from USD 117.3 Million in 2016, at a ...
(Date:5/25/2016)... , May 25, 2016 ... Size, Share, Development, Growth and Demand Forecast to 2022 ... Insulin Pump and Others)" published by P&S Market Research, ... $9,998.3 million in 2015, and it is expected to ... on type, the insulin pump segment is expected to ...
(Date:5/25/2016)... , May 25, 2016 ... employing the precision of circulating tumour DNA (ctDNA) ... announces the appointment of Professor Clive Morris ... medical leadership across the clinical development programme, scientific ... products help deliver significant improvements in clinical outcomes ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... W.S. Badger Co. Inc ... honored with a 2016 When Work Works Award for its use of effective workplace ... national When Work Works project administered by the Families and Work Institute (FWI) and ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... ... ... Connor Sports, through its Connor Cares initiative, will continue to ... Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and final ... and levels of the game, Connor Sports has committed to a significantly increased focus ...
(Date:5/26/2016)... ... 26, 2016 , ... The Woodlands at John Knox Village , Florida’s ... care for living and healing, celebrated its grand opening, today. The Woodlands at John ... provided by Empowered Staff. , “This is an incredibly fulfilling time for John Knox ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... There are ... more than 32 million cancer survivors worldwide. On Sunday, June 5, 2016, communities around ... annual National Cancer Survivors Day®. , National Cancer Survivors Day® is an annual ...
Breaking Medicine News(10 mins):